Daewoo Engineering & Construction Co. will develop wearable robots that can be worn by construction workers that could help prevent musculoskeletal disorders and maintain productivity.
The wearable robots consist of a waist support robot and a walking assistance robot. It will have sensors that will gather and analyze information about the workers' posture, weight, and working practices.
If their safety and efficacy are proven, Daewoo E&C will increase the supply of these robots to other industrial areas.
The company was selected in a contest held by the Korea Institute for Robot Industry Advancement to work in cooperation with local robotics startup Wirobotics and the Korea Orthopedics and Rehabilitation Center to develop and demonstrate smart work care services using wearable robot solutions.
The three parties, including Daewoo E&C, proposed the wearable robot and smart work care services concerning construction workers’ musculoskeletal issues and sustainable productivity.


US Stock Futures Steady as Cooling Inflation and Strong Earnings Support Markets
Oil Prices Rise as U.S.-Iran Tensions Grip Strait of Hormuz
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Google to Move All Pixel Production Out of China by 2027
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Oil Prices Rise as Iran-U.S. Tensions Threaten Strait of Hormuz Supply
Apple Develops China-Specific AI Model With Alibaba as Apple Intelligence Launch Nears
Yen Edges Higher as Weak US Data Dampens Fed Rate Hike Expectations
Japan Economy Grows 1.1% in Q2 as Consumer Spending Stalls
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Gold Prices Hold Near $4,400 as Fed Rate Hike Bets Fade
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



